Références

1. 1

   Pereira MP, et al. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification, and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018.

2. 2

   Zeidler C, et al. Chronic prurigo of nodular type: a review. Acta Derm Venereol. 2018.

3. 3

   Steinke S, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol. 2018.

4. 4

   Pereira MP, et al. Chronic nodular prurigo: clinical profile and burden. A European crosssectional study. J Eur Acad Dermatol Venereol. 2020.

5. 5

   Iking A, et al. Prurigo as a symptom of atopic and non¬atopic diseases: aetiological survey in a consecutive cohort of 108 patients. J Eur Acad Dermatol Venereol. 2013.

6. 6

   Boozalis E, Tang O, Patel S, et al. Ethnic differences and comorbidities of 909 prurigo nodularis patients. J Am Acad Dermatol. Octobre 2018.

7. 7

   Brenaut E et al. The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries. J Eur Acad Dermatol Venereol. 2019 Jan;33(1):157-s.

8. 8

   Misery L, Brenaut E, Torreton E et -al. Prevalence and management of chronic nodular prurigo (CNPG) in Brittany (France): estimation by matching two databases. J Eur Acad Dermatol Venereol 2021.

9. 9

   Mack M, (9 et al. The itch–scratch cycle: A neuroimmune perspective. Trends Immunol. 2018.

10. 10

    Oetjen LK, et al. Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch. Cell. 2017.

11. 11

    Gründel S, et al. Analysis of 325 patients with chronic nodular prurigo: clinics, burden of disease and course of treatment. Acta Derm Venereol. 2020;100(16):adv00269

12. 12

    Kowalski EH, et al. Clin Cosmet Investig Dermatol. 2019.

13. 13

    Wikström K, et al. Comorbidities of prurigo nodularis in Finland between 1996 and 2019. Acta Derm Venereol. 2021;101(7):adv00508

14. 14

    Huang AH, Canner JK, Khanna R, Kang S, Kwatra SG. Real-World Prevalence of Prurigo Nodularis and Burden of Associated Diseases. J Invest Dermatol. 2020.

15. 15

    Hello M et al. Dermatite atopique de l’adulte. Rev Med Interne. 2016.

16. 16

    Weidinger S et al. Atopic dermatitis. The Lancet. 2016.

17. 17

    Pereira MP, Ständer S. How to define chronic prurigo? Experimental Dermatology. 2019;28(12):1455-1460

18. 18

    Morgan CL, et al. Epidemiology of prurigo nodularis in England: a retrospective database analysis. Br J Dermatol. 2022. Epub Jan 26.

19. 19

    Keller JJ, Archives of Dermatological Research, 2023.

20. 20

    Hughes JM, et al. Medicines (Basel). 2020;7.pii:e4

21. 21

    Pereira MP, et al. JEADV. 2020;34(10):2373-2383

22. 22

    Misery et al. J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e602-e604

23. 23

    Stander S, Pereira MP, Berger T et al. IFSI-guideline on chronic prurigo including prurigo nodularis. Itch 2020; 5:1–13 [e42]

24. 24

    Aggarwal P et al. Clinical characteristics and disease burden in prurigo nodularis. Clin Exp Dermatol. 2021 Oct;46(7):1277-1284

25. 25

    Brenaut E et al. The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries. J Eur Acad Dermatol Venereol. 2019 Jan;33(1):157-s

26. 26

    Misery et al. JEADV. Impact of chronic prurigo nodularis on daily life and stigmatization. Volume 37, Issue 7, July 2023. Pages e908-e909